Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDTY.L Regulatory News (DTY)

  • There is currently no data for DTY

Response to statement made by Phoenix

13 Apr 2021 07:00

RNS Number : 2178V
Dignity PLC
13 April 2021
 

Dignity plc (the "Company")

 

Response to statement made by Phoenix UK Fund Limited ("Phoenix") on 12 April 2021 

 

The independent directors of the Company (the "Independent Directors") note the most recent statement by Phoenix published on its website on 12 April 2021. They note, in particular, the various comments made by Phoenix regarding potential strategies that may be adopted for the future direction of the group's business.

 

It should come as no surprise that many of the ideas disclosed in Phoenix's most recent letter are amongst those currently being assessed in detail by the Board. In the Company's letter to shareholders dated 29 March 2021, the Independent Directors commented on the fact that the vision and views on strategy of Phoenix and those of the Board were already closely aligned, such that the requisitioned shareholder meeting was wholly unnecessary. The Board is well-advanced in its detailed planning towards the announcement of a fully thought-through strategy plan, including the possibility of a distribution of the Crematoria business to existing shareholders on a pro rata basis. It was always intended that the Board would announce its vision for the Company at the time of the Company's AGM in June 2021 and this has been indicated to the market for some time.

 

The Independent Directors find the statements made by Phoenix relating to possible strategies (and public reference to unverified valuations for the Crematoria division, in particular) to be deeply irresponsible. There are significant nuances to any strategic plan of this nature before it can be made public. The interests of all stakeholders need to be carefully addressed including, in this instance, the interests of bondholders and employees, as well as shareholders. There also needs to be a full and complete understanding of all potential regulatory aspects, so that the Board can be sure of its capacity to deliver any publicly announced strategy before it is announced. The Board has already indicated that it is well-aware of the potential value of different elements of the business on a stand-alone basis and of course a core objective is to unlock value for the benefit of all shareholders. However, it is inappropriate to hypothesize on strategies until there is sufficient confidence in a methodology to deliver the same. That Phoenix has chosen to "go public" on these matters prematurely serves only as a further illustration of the lack of suitability of Gary Channon to be appointed as someone responsible for the executive function of the Company.

 

Not for the first time since the Board convened the General Meeting to consider the resolutions proposed, Phoenix has made ill-advised public statements which have been self-serving and have had little regard for the wider interests of shareholders and other stakeholders. The Board has been informed by proxy voting agents, ISS, Glass Lewis and PIRC, that they are advising their members to support the Board and vote against both resolutions at the forthcoming General Meeting. In light of Phoenix's most recent statements, the Independent Directors are more convinced than ever that it is in the best interests of shareholders to allow the current management team to finish its work without handing executive control to Phoenix.

 

The Independent Directors have no hesitation in repeating their recommendation that shareholders should vote AGAINST the resolutions.

 

The Independent Directors of Dignity plc

Gillian Kent, Dean Moore and Paul Humphreys

 

 

Chris Lane

Tilly Abraham

Buchanan +44 (0)20 7466 5000

www.buchanan.uk.com Dignity@buchanan.uk.com

 

13 April 2021

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RSPGPUCUCUPGPGP
Date   Source Headline
9th Jun 201711:36 amRNSResults of AGM
31st May 20172:06 pmRNSVoting Rights and Capital
19th May 20172:10 pmRNSBlock listing Interim Review
17th May 20174:38 pmRNSDirector/PDMR Shareholding
15th May 20174:35 pmRNSDirector/PDMR Shareholding
15th May 20177:00 amRNSFirst quarter trading update
28th Apr 20179:08 amRNSVoting Rights and Capital
27th Apr 20177:00 amRNSNotification of Q1 Trading Update
13th Apr 20175:11 pmRNSDirector/PDMR Shareholding
13th Apr 201711:03 amRNSRelease of the 2016 Annual Report
12th Apr 20171:09 pmRNSDirector/PDMR Shareholding
7th Apr 20175:51 pmRNSDirector/PDMR Shareholding
5th Apr 20171:00 pmRNSDirector/PDMR Shareholding
5th Apr 201712:10 pmRNSDirector/PDMR Shareholding
31st Mar 201710:19 amRNSVoting Rights and Capital
21st Mar 20173:06 pmRNSDirector Declaration
16th Mar 20171:57 pmRNSDirector(s)/PDMR Shareholding
13th Mar 20173:30 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
9th Mar 20174:55 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
8th Mar 20177:00 amRNSPreliminary Results
1st Mar 20174:44 pmRNSAdditional Listing
28th Feb 20174:20 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
28th Feb 201710:40 amRNSVoting Rights and Capital
13th Feb 20171:00 pmRNSDirectorate Change
8th Feb 20179:45 amRNSNotification of Preliminary Results
7th Feb 20174:46 pmRNSDirectorate Change
31st Jan 201710:50 amRNSVoting Rights and Capital
9th Jan 20173:35 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
30th Dec 201611:43 amRNSVoting Rights and Capital
13th Dec 20165:10 pmRNSDirector/PDMR Shareholding
30th Nov 20168:35 amRNSBlock listing Interim Review
17th Nov 201611:41 amRNSAdditional Listing
7th Nov 20167:00 amRNSThird quarter trading update
4th Nov 20162:45 pmRNSNon-Executive Director Change
31st Oct 20169:45 amRNSVoting Rights and Capital
30th Sep 201610:45 amRNSVoting Rights and Capital
15th Sep 20169:48 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
31st Aug 201610:45 amRNSVoting Rights and Capital
17th Aug 20169:06 amRNSBlock listing Interim Review
16th Aug 201612:40 pmRNSBlock listing Interim Review
9th Aug 201612:36 pmRNSReplacement - Director/PDMR Shareholding
9th Aug 201610:45 amRNSDirector/PDMR Shareholding
9th Aug 201610:45 amRNSDirector/PDMR Shareholding
9th Aug 201610:45 amRNSDirector/PDMR Shareholding
27th Jul 20167:00 amRNSInterim Results
28th Jun 20167:00 amRNSCompletion of acquisition of three crematoria
27th Jun 20169:30 amRNSNotification of Interim Results
17th Jun 20164:48 pmRNSDirector/PDMR Shareholding
16th Jun 20162:39 pmRNSDirector/PDMR Shareholding
10th Jun 20162:15 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.